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open access article under the CC BY-NSummary Background/Objective: As a widely used absorbable suture with antibacterial
property, triclosan- coated polyglactin suture (Vicryl Plus) has been extensively utilized to
reduce the occurrence rate of surgical site infections (SSIs) in orthopaedic surgery. However,
the potential toxicity and side-effects of triclosan raised increasing concerns about its biolog-
ical safety. This study aimed to investigate the antimicrobial activity and biocompatibility of
quaternised chitosan-coated Vicryl suture (HV) both in vitro and in vivo.
Methods: In this study, a modified chitosan derivate, (hydroxypropyltrimethyl ammonium
chloride chitosan, HACC), was coated over the surface of the absorbable Vicryl
suture. Two standard bacteria strains, Staphylococcus epidermidis (ATCC35984) and meth-
icillin-resistant Staphylococcus aureus (ATCC43300), were selected to evaluate bacterial
adhesion and biofilm formation on the sutures at 6, 24 and 48 h in vitro. Additionally, human
skin-derived fibroblasts cells were used to test the cytocompatibility of the sutures.
Furtherly, sutures contaminated with methicillin-resistant S. aureus were implanted subcu-
taneously in SD rats in order to confirm the in vivo antibacterial performance and biocom-
patibility.
Results: We found that HACC-coated Vicryl suture (HV) exhibited significant anti-bacterial
effects on the two tested strains. The bacterial attachment and biofilm formation on
the surface of the HV sutures were found to be comparable to that of Vicryl Plus sutures
(VP). Moreover, all the four tested sutures presented good cytocompatibility with human
skin-derived fibroblasts cells. Histology and immunohistochemistry results indicated
that the infections and inflammations were significantly inhibited around the HV and VP su-
tures.y Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People’s
y, School of Medicine, 639 Zhizaoju Road, Shanghai 200011, People’s Republic of China.
.-T. Tang).
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50 Y. Yang et al.Conclusion: In general, the present study demonstrated that the quaternised chitosan
coating is a flexible and cost-effective alternative strategy to prevent the suture related
surgical site infections in orthopaedic practices.
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Surgical site infections (SSIs) account for the most common
complications postsurgery, which inevitably increases the
prolonged hospitalisation, medical costs, and secondary
patient morbidity [1,2]. Approximately 40% of all hospital-
acquired infections are closely related to SSIs among sur-
gical patients [3]. The incidence of infection involved in
orthopaedic traumatic procedures has been estimated to
be approximately 27% in civilians and 40% in war injuries,
thus, infection serves as a major challenge and complica-
tion of orthopaedic trauma and reconstruction surgery [4].
Moreover, periprosthetic joint infection after total hip
arthroplasty remains one of the most devastating compli-
cations [5]. As a foreign material to the surgical region, the
implanted suture always functions as a nidus for infection
under the condition of wound contamination, leading to
recalcitrant and recurrent infections [6].
To reduce bacterial attachment to surgical sutures,
triclosan-coated polyglactin sutures (Vicryl Plus, VP) with
antibacterial potential were developed and have been
widely used in the United States and Europe since 2003. Its
efficacy in preventing SSIs has been extensively investigated
and verified by various clinical cohort studies, randomised
controlled trials, and meta-analysis, which consistently
reach the conclusion that such an antibiotic-coated suture
could effectively decrease the SSIs rates after surgery
[7e11]. Triclosan, a broad-spectrum antibacterial agent, has
been considered to interfere with bacterial lipid synthesis
and consequently decrease bacterial colonisation of the
suture material in both in vitro and in vivo studies [12,13].
Currently, the potential toxicity and side-effects of triclosan
have raised increasing concerns about its biological safety.
Several reports indicated that triclosan was physiologically
harmful to the reproductive health in humans and animal
models [14,15]. Triclosan has also been reported to promote
Staphylococcus aureus nasal colonisation, resulting in rele-
vant adverse effects on the environment and human health
[16]. Metal ions with good antibacterial property, such as
silver, have been used to modify the sutures [17,18]. How-
ever, cell and tissue compatibility have yet to be fully
established. In addition, nanostructured sutures also showed
desirable bacterial repellence performances, but their
topography-based antibacterial property may not be suit-
able for combating contaminated SSIs [19]. Therefore,
exploitation of alternative suture materials with excellent
antibacterial activity and good biocompatibility is of major
scientific and clinical significance.
It has been found that the antimicrobial activity and
biocompatibility of hydroxypropyltrimethylammonium chlo-
ride chitosan (HACC), a water-soluble chitosan derivative,could be adjusted by varying the degree of substitution
(DS) of quaternary ammonium [20]. Our previous studies
indicated that HACC exhibited excellent antibacterial po-
tential and good biocompatibility both in vitro and in vivo
[21e24]. HACC exhibited a broad spectrum of antibacterial
activity because of the electrostatic interaction between
the positively charged quaternary ammonium groups of
HACC and the negatively charged phosphoryl groups of
the phospholipid components of bacterial membranes,
which affected the cytoplasmic membrane integrity and
eventually led to cell death [25,26]. Thus, such a physically
antibacterial effect of HACC on microbes may not induce
antibiotic resistance and enzymatic dysfunction, as previ-
ously reported to be caused by triclosan [14e16]. In the
present study, we investigated the antimicrobial activity
and biocompatibility of this innovative HACC-coated Vicryl
(HV) suture both in vitro and in vivo. In addition, absorbable
Vicryl (V), VP, and gentamicin-coated Vicryl (GV) sutures
were also studied and compared. We hypothesised that the
HACC coating over the suture could significantly improve
the antibacterial activity with good biocompatibility, which
may pave the way for developing new cationic antimicrobial
agent-coated sutures in future orthopaedic surgery.
Materials and methods
Materials
Gentamicin sulphate salt [molecular weight (MW)
Z 547.62 g/moL], triclosan (MWZ 289.50 g/moL), glycidyl
trimethylammonium chloride (MWZ 151.63 g/moL), and
type I collagen from calf skin were purchased from Sigma-
Aldrich, Ltd. (St. Louis, MO, USA). Chitosan (MWZ 50,000 g/
moL) with 87% N-deacetylation was purchased from
Zhejiang Yuhuan Ocean Biochemistry Co., Ltd., Yuhuan,
Zhejiang, China. HACC (MWZ 200,000 g/moL) with a 26%
DS of quaternary ammonium was prepared by combining
chitosan and GTMAC, as previously reported [20,22]. All
other chemical reagents were of analytical grade and
were purchased commercially.
Preparation of gentamicin and HACC-coated
sutures
VP antibacterial absorbable sutures and V absorbable su-
tures were purchased from Ethicon Ltd. (Somerville, NJ,
USA). Firstly, type I collagen was dissolved in 5mM acetic
acid at a concentration of 0.5 mg/mL according to the
provided manufacture’s protocols. Subsequently, genta-
micin or HACC with a mass concentration of 0.2 wt% was
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sonicated in an ultrasonic bath at 150 W (B3500S-MT,
Branson, Shanghai, China operating at a frequency of 50 Hz
for 5 minutes to obtain the uniformly dissolved solutions.
Then, Vicryl absorbable sutures were immersed overnight
in the solutions to form the antibacterial agent-coated su-
tures as described in a previous report [27]. After the
adsorption of collagen, the sutures were dried at room
temperature for 24 hours. In each group, the same suture
size was used for the in vitro (2-0) and in vivo (4-0) ex-
periments, and all the tested sutures were cut into 2.5 cm
in length for the in vitro assay (except for the sutures with
lengths of 10 cm used for the in vitro drug release mea-
surement). All prepared GV and HV sutures were sterilised
by 25 kGy of 60Co irradiation before the biologic experi-
ments were conducted.
Surface characterisation
The elemental distribution of the sutures was determined
using energy-dispersive X-ray spectroscopy (JEOL JSM-
6310LV, JEOL Ltd., Tokyo, Japan). Meanwhile, the surface
morphologies of the four sutures were examined using a
scanning electron microscope (SEM, HITACHI SU8220,
Tokyo, Japan) at an electron acceleration voltage of 3.0 kV.
Characterisation of drug release from sutures
The release kinetics of the gentamicin and HACC from the
sutures were determined as described in our previous studies
[28,29]. Five sutures coated with gentamicin (GV) or HACC
(HV) were each individually immersed in 2 mL of phosphate-
buffered saline (PBS) at 37C and agitated at 100 rpm. V
immersed in 2 mL of PBS served as blank controls. All drug-
coated sutures were taken after specific intervals to
confirm the release kinetics with a periodic collection for up
to 144 hours. The solutionwas replacedwith 2mLof fresh PBS
every time sutures were collected. The colorimetric evalua-
tion was used to determine the released gentamicin content
[30]. In brief, the collected gentamicin solution, isopropanol,
and o-phthaldialdehyde reagent (560 mL of sodium borate
solution added with 2.5 g o-phthaldialdehyde, 62.5 mL of
methanol, and 3 mL of 2-mercaptoethanol) were adequately
mixed and incubated at 37C for 30 minutes. Then, the
absorbance of these products was determined at 332 nm
using a Synergy HT microplate reader (Bio-Tek Instruments
Ltd., Winooski, VT, USA).
In addition, the released HACC content was confirmed
using the anthrone sulphuric acid reaction [31]. Briefly,
50 mL of solution taken from no drug-loaded sutures, 50 mL
of solution collected from HACC-coated sutures, and 50 mL
of standard glucose solution with gradient concentrations
were individually placed into 96-well plates (Costar; Corn-
ing Incorporated, New York, NY, USA), and then gently
vortexed (Vortex-Genie 2; Scientific Industries, New York,
NY, USA) and incubated at 4C for 15 minutes. Subse-
quently, 100 mL of freshly prepared anthrone solution was
added into each well. Then, the plate was thoroughly vor-
texed and incubated in a water bath at 92C for 3 minutes.
The absorbance of these products was determined at
630 nm after 5 minutes cooling at room temperature. Astandard curve with known concentration of gentamicin
(yZ 0.003x þ 0.026, R2Z 0.986, x and y denote the
gentamicin concentration and absorbance, respectively) or
glucose (yZ 0.002x þ 0.057, R2Z 0.982, x and y denote
the HACC concentration and absorbance, respectively)
standard samples was used to determine the unknown
gentamicin or HACC concentrations (mg/mL), respectively.
After a thorough degradation in type I collagenase water
solution (1 mg/mL, Sigma-Aldrich) for 48 hours at 37C
under an agitation at 100 rpm, the total drug loading
amounts of GV and HV sutures were calculated according to
the methods mentioned above.
Preparation and characterisation of bacteria
Staphylococcus epidermidis (ATCC35984) and methicillin-
resistant S. aureus (MRSA, ATCC43300) were purchased
from the American Type Culture Collection (Manassas, VA,
USA). The cells were suspended in Mueller-Hinton Broth
(MHB, Solarbio, Beijing, China) at 1  108 colony-forming
units (CFUs)/mL after overnight tryptic soy broth culture,
according to a McFarland standard protocol (Beijing Zhe-
cheng Science and Technology Co., Ltd., Beijing, China).
The minimum inhibition concentrations (MICs) of triclosan,
gentamicin, and HACC with a 26% DS of quaternary ammo-
nium against these two tested strains were determined
according to a previously reported microtiter broth dilution
method [32]. In brief, 100 mL of bacteria suspension in MHB
with a density of 1.0  106 CFUs/mL was inoculated into 96-
well plates (Costar in the presence of triclosan, gentamicin,
and HACC with a 26% DS at different final concentrations
(0 mg/mL, 1 mg/mL, 2 mg/mL, 4 mg/mL, 8 mg/mL, 16 mg/mL,
32 mg/mL, 64 mg/mL, 128 mg/mL, 256 mg/mL, 512 mg/mL,
and 1024 mg/mL). The inoculated microplates were incu-
bated at 37C for 24 hours before further analysis.
In vitro anti-bacterial performance
Zone of inhibition assay
The zone of inhibition assay was used to compare the
antimicrobial efficacy against the two tested strains for
these sutures [33]. In brief, bacterial suspension at a con-
centration of 1  108 CFUs/mL in MHB medium was inocu-
lated onto the 10 cm tryptic soy agar (TSA) plate to obtain a
uniform bacterial overlay, then the prepared sutures were
placed on the bacterial overlay and gently pressed in. In-
hibition zones of all the tested sutures were photographed
and calculated after 24 hours incubation at 37C.
Bacterial adhesion and biofilm formation assay
Bacterial adhesion on the sutures was determined using the
spread plate method [34]. A volume of 1 mL of bacterial
suspensions at an amount of 1  106 CFUs/mL inMHBmedium
was added into wells containing V, VP, GV, and HV sutures,
and these were then incubated at 37C for 4 hours. The
adherent bacteria on the sutures were dislodged by ultra-
sonication in the ultrasonic bath operating at a frequency of
50 Hz for 5 minutes. The solutions collected after ultra-
sonication were then serially diluted 10-fold and were plated
in triplicate onto TSA. They were then transferred into an
incubator with a temperature of 37C and incubated for 24
52 Y. Yang et al.hours. The number of colonies on the TSA was counted, and
the ultimate number of CFUs on the suturewas the number of
colonies multiplied by the dilution ratio. The CFUs of each
group were normalised to the counts from the V sutures.
The tissue culture platemethodwas used to detect biofilm
formation [35]. After 24 hours and 48 hours of incubation, the
sutures were dried at 60C for 1 hour. Then, the biofilms on
the sutures were stained with 500 mL of a 0.1% (wt/vol)
aqueous solution of crystal violet (CV; Sigma-Aldrich) at room
temperature for 10 minutes. The sutures were then dried at
37C for 2 hours. Then, biofilm formation was quantified by
solubilisation of the CV stain in 200 mL of 30% (wt/vol) glacial
acetic acid for 10 minutes with shaking at 300 rpm. The CV
concentration was determined at 492 nm. The mean absor-
bance obtained from themediumcontrol well was subtracted
from the test absorbance values.
Confocal laser scanning microscopy and SEM observation
MRSA (ATCC43300) was selected for the observation of
confocal laser scanning microscopy (CLSM) and SEM. After 6
hours and 24 hours of co-culture, the sutures were gently
washed three times with PBS, and then stained with 500 mL of
combination dye (LIVE/DEAD BacLight viability kits, L7012;
Thermo Fisher Scientific, Waltham, MA, USA) and were
visualised using CLSM (Leica TCS SP8, Leica Microsystems,
Wetzlar, Germany). Viable bacteria with intact cell mem-
branes appearfluorescent green,whereas nonviable bacteria
with damaged cell membranes appear fluorescent red. The
three-dimensional imageswereacquired from randomsuture
positions. The adherent bacteria and biofilm on the sutures
were then dehydrated through a series of graded ethanol
solutions (30%, 50%, 70%, 80%, 90%, and 100%) for 10 minutes
each after fixation in 2.5% glutaraldehyde solution for 2
hours at 4C. The sutures were subsequently examined using
SEM after critical-point drying and coating by gold sputter.
In vitro cytocompatibility
Human skin-derived fibroblasts, isolated and expanded as
previously described [36], were selected to evaluate the
cytocompatibility of these sutures in vitro. A cell counting
kit-8 (CCK-8) assay was used to analyse the cell proliferation
at 6 hours, 24 hours, 72 hours, and 120 hours according to the
previously reported protocols [37]. In brief, cell suspension
was seeded into a 24-well plate containing various sutures
at a density of 3.0  104/cm2, with a-MEM (Modified Eagle’s
Medium) medium as a blank control. The sutures were
removed, and 50 mL of CCK-8 solution (Dojindo Molecular
Technologies Inc., Kumamoto, Japan)was added to thewells
without sutures at each time point. The mixed solutions
were incubated for 3 hours, and then read at 450 nm with
620 nm as the reference wavelength. The mean absorbance
value (optical density, OD) obtained from the blank control
was subtracted from the ODs of the tested groups.
In addition, the cell viability was further analysed using a
Live/Dead Cell kit (ab115347, Abcam, Cambridge, UK)
through the evaluation of flow cytometry. The cell seeding
procedures were similar to those of the cell proliferation,
except that the cell seeding density was 1.5  105/cm2 in a
six-well plate. After a 24-hour co-culture, cells were trypsi-
nised and collected, staining with 200 mL of combination dye
for 10 minutes according to the manufacturer’s protocol. Allsamples were run on a BD LSRFortessa (BD Biosciences, San
Jose, CA, USA) and data were analysed using FlowJo software
(TreeStar, Ashland, OR, USA).
Anti-infective potential and biocompatibility
in vivo
Animal experiment
We here established a subcutaneous implantation model to
evaluate the anti-infection performances of the sutures
in vivo. All experimental procedures were approved and
performed in accordance with the guidelines of the Animal
Ethics Committee of Shanghai Ninth People’s Hospital. In
brief, 24 6-week-old Sprague-Dawley male rats weighing
approximately 300 g were assigned randomly to four inde-
pendent groups: V, VP, GV, and HV. The rats were initially
anaesthetised using an intraperitoneal injection of 1%
pentobarbital sodium (100 mg/kg body wt) and both of the
lateral thighs were shaved and cleaned with 2% iodine prior
to the procedure. An approximately 3 cm longitudinal skin
incision was made over the lateral thighs and reached the
musculoaponeurotic layer, then the superficial muscle was
incised at a length of approximately 2.5 cm. Prior to the
suture of the incised superficial muscle in the left thigh,
these tested sutures were incubated with the prepared
ATCC43300 suspensions (1  106 CFUs/mL in PBS) for 5 mi-
nutes. Meanwhile, sutures without bacteria inoculation
were implanted in the right thigh to evaluate the in vivo
biocompatibility. Then, the skin closure was performed
using 4-0 Mersilk nonabsorbable sutures (Ethicon). The rats
were housed in ventilated rooms and allowed to eat and
drink ad libitum after surgery. The animals were sacrificed
21 days after implantation. No antibiotics were adminis-
tered, and no mortality occurred during the experiment. All
animal operations were performed by the same person
under the same experimental condition.
Histopathological evaluation
The implanted sutures and the peri-implant tissues in each
group were harvested at 21 days after implantation, and
then immersed in 4% neutral-buffered formaldehyde for 48
hours. The collected specimens were then embedded into
paraffin. The embedded specimens were cut into sections
parallel to the cross-section of the sutures and prepared at
a thickness of 5 mm (EXAKT-400 grinding equipment, SLEE
Medical, Mainz, Germany). Haematoxylin and eosin and
Giemsa staining were used to assess morphology and bac-
terial contamination, respectively. Meanwhile, immuno-
histochemical staining was also used to observe the
inflammatory cells (lymphocyte and macrophage) sur-
rounding the sutures according to the previous protocol
[38]. In brief, prepared slices were incubated overnight at
4C with anti-CD3 antibody (1:100, ab16669, Abcam, Cam-
bridge, UK) or anti-CD68 antibody (1:400, ab955, Abcam)
after deparaffinisation, rehydration with descending con-
centrations of ethanol, quenching of endogenous peroxi-
dase, and blocking with 3% bovine serum albumin. Then,
the sections were visualised using diaminobenzidine
(DakoCytomation, Glostrup, Denmark) containing bio-
tinylated anti-rat IgG secondary antibody. The histological
images were captured on a Leica AF6000 (Leica Micro-
systems, Wetzlar, Germany).
Table 1 The initial and total releasing of drugs in 144
hours.
Sutures Loaded
drugs
Total drug-loaded
(mga/one suture)
Initial
release
(mgb)
Total
release
(mg)
GV Gentamicin 318.38 92.90 117.16
HV HACC 349.48 143.45* 175.73*
* p < 0.05 compared with GV sutures (nZ 5).
GVZ gentamicin-coated Vicryl suture; HVZ hydroxypropyl-
trimethylammonium chloride chitosan (HACC)-coated Vicryl
suture.
a The total drug loading amount in the sutures was measured
after a thorough degradation in type I collagenase water
solution.
b The amount of drug released in the initial burst release
period before the drug release rate became nearly constant.
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All data are expressed as the mean  standard deviation.
All in vitro experiments were repeated three times. One-
way analysis of variance (ANOVA), the least significant
difference test and nonparametric test (Mann-Whitney U
test) were used to determine the level of significance;
p < 0.05 was defined as statistically significant, and
p < 0.01 was considered highly statistically significant. All
statistical analyses of the data were performed using SPSS
software (v19.0, IBM Corp, Armonk, NY, USA).
Results
Morphological characterisation and drug releasing
The elemental distributions of C, O, and N in the sutures
obtained by Energy Dispersive Spectroscopy (EDS) are
shown in Figure 1A, and the images indicate that elementalFigure 1 Surface and drug releasing characterisation of absorbable Vicryl suture (V), Vicryl Plus (VP) suture, gentamicin-coated
Vicryl (GV) suture and hydroxypropyltrimethylammonium chloride chitosan (HACC)-coated Vicryl (HV) suture. (A) Energy Dispersive
Spectroscopy (EDS) elemental mapping of a randomly selected area showing the distributions of C, O, and N elements; (B)
representative scanning electron microscopy (SEM) images; (C) cumulative drug release profiles from GV (gentamicin) and HV
(HACC) sutures (nZ 5), expressed in mg/mL.
Table 2 The minimum inhibiting concentrations of the
two tested strains.
Compounds MICs (mg/mL)
ATCC 35984 ATCC 43300
Triclosan 32 64
Gentamicin 16 512
HACC (26%DSa) 32 64
HACCZ hydroxypropyltrimethylammonium chloride chitosan;
MICZminimum inhibition concentration.
a Degree of substitution of quaternary ammonium.
54 Y. Yang et al.N derived from gentamicin and HACC existed in GV and HV
sutures exclusively. The morphology of the sutures was
observed using SEM. As demonstrated in Figure 1B, the gaps
between the threads of the sutures were evidently coveredFigure 2 Comparison of the antibacterial efficacy of various s
Photographed inhibition zone affected by different sutures; (B) qua
(n Z 5). GVZ gentamicin-coated Vicryl suture; HVZ hydroxypro
suture; VZ absorbable Vicryl suture; VPZ Vicryl Plus suture.by the coated drugs incorporated in collagen. These results
could be evidence of successfully coated gentamicin and
HACC over the surfaces of the sutures.
As shown in Figure 1C, there is higher sustained drug
release from HV than from GV (p < 0.05). The majority of
the gentamicin or HACC was released from the sutures after
approximately 24 hours. We found that drugs released from
the sutures could be divided into two parts: initial burst
release and relatively slow release. The amount of genta-
micin or HACC released from the sutures remained nearly
constant after a high initial burst release. As demonstrated
in Table 1, the total drug loading of gentamicin and HACC
from sutures was 318.38 mg and 349.48 mg, respectively
(p > 0.05). The initial release of gentamicin and HACC from
sutures was 92.90 mg and 143.45 mg, respectively,
(p < 0.05). In addition, the results indicated that approxi-
mately 60% and 50% drugs were retained in the GV and HV
sutures after 144 hours releasing, respectively (p < 0.05).utures against the two strains after 24 hours incubation. (A)
ntification of the inhibition zone. * p < 0.01 compared with GV
pyltrimethylammonium chloride chitosan (HACC)-coated Vicryl
Anti-infective quaternised chitosan-coated suture 55Antibacterial properties of the drugs contained in
sutures
The phenotype classification and biofilm-forming capacity
were confirmed previously [22]. The MICs of triclosan,
gentamicin, and HACC with a 26% DS were 32 mg/mL, 16 mg/
mL, and 32 mg/mL against S. epidermidis (ATCC35984),
respectively (Table 2). Alternatively, the MICs of triclosan,
gentamicin, and HACC with a 26% DS were 64 mg/mL,
512 mg/mL, and 64 mg/mL against MRSA (ATCC43300),
respectively. These results indicated that triclosan and
HACC with a 26% DS showed significant antibacterial capa-
bilities on the antibiotic-resistant strain (ATCC43300),
which is difficult to be inhibited by gentamicin.
Antibacterial potential and cytocompatibility
in vitro
Zone of inhibition
In order to compare the antimicrobial efficacy in vitro,
we photographed and calculated the inhibition zones in
various groups after 24 hours incubation. As shown in
Figure 2, the areas of the inhibition zone of the three
antibiotic-coated sutures (VP, GV, and HV) exhibitedFigure 3 Bacterial adhesion and biofilm formation evaluation. (A)
the four sutures after 6 hours of incubation. (B) The number of viab
from V sutures for the two tested strains at 6 hours, as measured u
two tested strains on the surfaces of various sutures at 24 hours and
method. * p < 0.01 compared with the other three sutures (n Z
*** p < 0.05 compared with HV suture (nZ 5). #p < 0.05 compared
HVZ hydroxypropyltrimethylammonium chloride chitosan (HACC)-
Plus suture.no significant differences for the strain ATCC35984
(p > 0.05), whereas the inhibition zone of the GV against
the strain ATCC43300 was evidently lesser than VP and HV
(p < 0.01).
Inhibition of bacterial adherence and biofilm formation
The surviving number of the two strains on different sutures
at 6 hours was quantitatively determined by the spreading
plate method, as shown in Figures 3A and 3B. The numbers
of viable bacteria on the surface of V were significantly
higher than those on the other three sutures (p < 0.01), and
no differences were observed among the VP, GV, and HV for
the strain ATCC35984 (p > 0.05). However, the numbers of
viable bacteria of methicillin-resistant ATCC43300 on the
surface of GV were found to be significantly higher than
those on the VP and HV sutures (p < 0.01). Considering log-
reduction with respect to V, ATCC35984 on VP, GV, and HV
sutures were reduced 1.29-log, 1.65-log, and 1.37-log at 6
hours, respectively, and ATCC43300 on VP, GV, and HV su-
tures were reduced 0.82-log, 0.15-log, and 0.78-log,
respectively.
The biofilm-formation evaluation using the tissue culture
plate method is shown in Figures 3C and 3D. The OD492
values of the VP, GV, and HV groups for ATCC35984 were
significantly lower than those of the V group at 24 hours andRepresentative images of adherent bacteria on the surfaces of
le bacteria on VP, GV, and HV sutures normalised to the counts
sing the spread plate method. (C), (D) Biofilm formation of the
48 hours, respectively, as evaluated by the tissue culture plate
5). ** p < 0.01 compared with VP and HV sutures (n Z 5).
with GV suture (nZ 5). GVZ gentamicin-coated Vicryl suture;
coated Vicryl suture; VZ absorbable Vicryl suture; VPZ Vicryl
Figure 4 Confocal laser scanning microscopy (CLSM) observation of bacterial viability and biofilm formation of ATCC43300 on the
surfaces of V, VP, GV, and HV sutures at 6 hours and 24 hours after the sutures were stained with the BacLight Live/Dead stain.
Bacteria were stained with green fluorescent SYTO 9 and red fluorescent propidium iodide, which denoted live and dead cells,
respectively. GVZ gentamicin-coated Vicryl suture; HVZ hydroxypropyltrimethylammonium chloride chitosan (HACC)-coated
Vicryl suture; VZ absorbable Vicryl suture; VPZ Vicryl Plus suture.
56 Y. Yang et al.48 hours (p < 0.01). In addition, the OD492 values of the GV
group for ATCC35984 were also significantly lower than HV
at 48 hours (p < 0.05). For the methicillin-resistant strain
ATCC43300, the OD492 values of the VP and HV groups wereFigure 5 Scanning electron microscopy (SEM) observation of ba
surfaces of V, VP, GV, and HV sutures at 6 hours and 24 hours.
trimethylammonium chloride chitosan (HACC)-coated Vicryl suturesignificantly lower than those of the V and GV groups at the
two time points (p < 0.01). The OD492 values of the GV
group were significantly lower than those of the V at the
two time points (p < 0.05). Our results demonstrated thatcterial adhesion and biofilm formation of ATCC43300 on the
GVZ gentamincin-coated Vicryl suture; HVZ hydroxypropyl-
; VZ absorbable Vicryl suture; VPZ Vicryl Plus suture.
Anti-infective quaternised chitosan-coated suture 57all three antibiotic-coated sutures displayed obvious anti-
bacterial effects on the ATCC35984, but discrepant effects
on the ATCC43300.
CLSM and SEM observation
Bacterial adhesion and biofilm formation of ATCC43300
on the surfaces of various sutures at 6 hours and 24
hours were observed using CLSM and SEM. As shown in
Figure 4, live bacteria appeared fluoresced green, and
dead bacteria fluoresced red. At 6 hours, considerably
less green fluorescence and scattered red fluorescence
could be found on the VP and HV sutures, which indi-
cated a significant decreased level of adherent surviving
bacteria on the VP and HV sutures. An extraordinarily
dense green fluorescence, indicating biofilm formation,
was detected on the V and GV sutures at 24 hours.
Conversely, a sparse red and green fluorescence,Figure 6 In vitro cytocompatibility of various sutures co-culture
and 120 hours. (A), (B) Cell proliferation and tendency measured us
the Live/Dead assay after 24 hours incubation using flow cytometry.
black polygon gate identifies live cells and the number indicates the
in various sutures after a 24-hour co-culture. FITCZ fluoresc
HVZ hydroxypropyltrimethylammonium chloride chitosan (HACC)-
Plus suture.indicating dead colonies and no biofilm formation, was
observed on the VP and HV sutures. Meanwhile, the SEM
observations further supported the CLSM results as
shown in Figure 5.
In vitro cytocompatibility evaluation
Cell proliferation measured using the CCK-8 assay was
similar in all four groups during the 120 hours co-culture
period (p > 0.05) (Figures 6A and 6B). Additionally, cells
exhibited good viability in all four groups according to the
results of flow cytometry (Figures 6D and 6D). Therefore,
our results disclosed the good cytocompatibility in these
groups in vitro.
Histopathological evaluation
The morphological changes and bacterial residues on the
transverse slices are evaluated by haematoxylin and eosind with human fibroblasts (hFBs) at 6 hours, 24 hours, 72 hours,
ing the cell counting kit-8 assay. (C) Cell viability evaluated by
Live cells are on the x-axis and dead cells are on the y-axis. The
percent of live cells. (D) Quantification of the ratio of live cells
ein isothiocyanate; GVZ gentamicin-coated Vicryl suture;
coated Vicryl suture; VZ absorbable Vicryl suture; VPZ Vicryl
Figure 7 Histological evaluations of contaminated sutures with surrounding soft tissues obtained at 21 days after implantation.
Immunohistochemical staining (CD3) was used to confirm the lymphocyte infiltration. Haematoxylin and eosin (H&E) and Giemsa
staining were used to assess morphology and bacterial contamination, respectively. The black arrowheads indicate fibroplasia and
inflammatory cell infiltration. The red arrowheads indicate lymphocyte infiltration and the red arrows indicate residual bacteria.
GVZ gentamicin-coated Vicryl suture; HVZ hydroxypropyltrimethylammonium chloride chitosan (HACC)-coated Vicryl suture;
SZ sutures; VZ absorbable Vicryl suture; VPZ Vicryl Plus suture.
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monocyte and macrophage infiltration is confirmed by
immunohistochemical staining. As demonstrated in
Figure 7, typical signs of soft-tissue infection around the
sutures as manifested by the development of local necro-
sis, fibroplasia, and inflammatory cells infiltration, were
found in the V and GV groups, and lots of bacteria are
observed in the area around the sutures as manifested in
the Giemsa slices at high magnification. In contrast, his-
tological slices from the VP and HV groups exhibited small
necrosis formation and significantly reduced inflammatory
reaction, and the number of bacteria colonised around the
sutures reduced dramatically. These results indicate that
the VP and HV groups presented effective anti-infection
performances.
Meanwhile, we further investigated the in vivo
biocompatibility of these sutures. As shown in Figure 8,
there was slight inflammatory reaction observed in all
groups, and the macrophage infiltration was not obvious,
which was consistent with in vitro cytocompatibility
results.Discussion
Implanted sutures may potentiate postoperative SSIs in
the presence of wound contamination, since it lowers the
inoculation amount required for infection in a clean sur-
gical site [6,39]. The overall risk of SSIs following hip
fracture surgery has been reported to be 4.97%, with
approximately 30% cases among them representing deep
infection [40]. Furthermore, the cost of treating a patient
with SSIs has been counted to be £31,164, rising to £38,464
if the pathogenic bacteria is MRSA [41]. Routine antibiotic
prophylaxis produced limited effects on decreasing the
rate of SSIs in open reduction and internal fixation, espe-
cially under the contamination of drug-resistant strains
[42]. All suture surfaces, regardless of structural configu-
ration, can provide a hospitable environment for bacterial
attachment [6]. Therefore, preventing bacterial adher-
ence and biofilm formation on the surface of the implan-
ted sutures would appear to be a favourable strategy for
the risk reduction of SSIs. In this study, an innovative
approach to solving these intractable challenges was
Figure 8 Histological evaluations of noncontaminated sutures with surrounding soft tissues. Haematoxylin and eosin (H&E) and
immunohistochemical staining (CD68) were used to observe the morphology and macrophage infiltration, respectively. The red
arrowheads indicate macrophage infiltration. GVZ gentamicin-coated Vicryl suture; HVZ hydroxypropyltrimethylammonium
chloride chitosan (HACC)-coated Vicryl suture; SZ sutures; VZ absorbable Vicryl suture; VPZ Vicryl Plus suture.
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suture.
The initial adherence of microbes to biomaterial sur-
faces is considered to be the key step for the pathogen-
esis of foreign body infections, and bacterial adhesion
from 4e6 hours after implantation has been shown to be
critical to biofilm formation [43]. S. epidermidis and
MRSA, which are two common bacterial strains recovered
from infected and noninfected patients according to a
previous investigation [6], were selected to test the
antimicrobial performances of the four different sutures.
We concluded that gentamicin and HACC were success-
fully coated over the surfaces of the sutures according to
the results of the morphological and elemental charac-
terisation analysed above, which laid the foundation for
the proceeding of the in vitro and in vivo antibacterial
evaluations. In addition, we examined the drug releasing
characteristics of sutures GV and HV, indicating that the
initial drug release time of GV and HV was extended to
approximately 24 hours. The total amounts of gentamicin
and HACC released from the sutures were 117.16 mg and
175.73 mg, respectively, which were all above the MICs of
S. epidermidis (ATCC35984), as analysed in Table 2.
However, the total released gentamicin is insufficient to
inhibit the adhesion and biofilm formation of MRSA
(ATCC43300). Although nearly half of HACC was not
released and retained in HV sutures, we may conclude
that the released HACC is sufficient to produce desirable
antibacterial performances.
Even though the antimicrobial coating prevents the
accumulation of microbes on medical materials to some
degree, it is very difficult to eliminate or kill bacteria thatadhered to suture material once a biofilm has formed and
matured [44]. The HACC-coated sutures exhibited parallel
antibacterial activity, including significantly inhibited bac-
terial adherence and biofilm formation compared with
triclosan-coated sutures. However, the gentamicin-coated
sutures demonstrated limited antimicrobial capability
against antibiotic resistant strains due to relatively high
MICs. Meanwhile, all four different sutures displayed good
biocompatibility both in vitro and in vivo. Although the
short-term biocompatibility of the triclosan-coated suture
was shown in our study, its potential adverse effects have
been reported in previous studies [14e16]. Moreover, we
have roughly estimated the fabrication cost of these anti-
bacterial sutures according to the referred price of
commercially purchased triclosan, gentamicin, and chito-
san, indicating that per gram production cost of HACC was
approximately 1/1000 and 1/50 of triclosan and gentamicin
involved in the manufacture of antimicrobial agent-loaded
sutures, respectively. Thus, we conclude that HACC may be
a new and effective candidate for the fabrication of anti-
bacterial sutures in the future, which is supposed to
demonstrate good anti-infection potential, reduced side-
effects, and significantly alleviated medical expenses.
Although the bacterial residues found in the Giemsa
slices of the VP and HV groups were significantly more
decreased than those in the V and GV groups, the microbes
were not completely eradicated, which may be closely
associated with the relatively higher doses of bacteria
inoculation (1  106 CFUs/mL) in our in vivo assay as
compared with the numbers clinically contaminating bac-
teria in a surgical site [6]. In addition, the HACC was coated
over the surfaces of the absorbable sutures, which may
60 Y. Yang et al.restrict the loading capacity of these antibacterial sutures.
Furthermore, the drug eluting rate may be accelerated due
to the inevitable digestion by collagenase under an in vivo
environment. Therefore, the current study just proved the
feasibility of an antimicrobial cation agent serving as the
suture coating material, and future studies need to be
followed to improve the loading efficiency, as well as
releasing time of HACC in the suture.
Conclusion
Both in vitro and in vivo studies demonstrated that the
HACC-coated absorbable Vicryl sutures showed significant
antibacterial potential (especially for drug-resistant
strains) and good biocompatibility, which implies that
such an antimicrobial agent-loaded suture may be an
alternative option to prevent postoperative SSI in ortho-
paedic procedures.
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